The positive effect of moderate walking exercise on chemerin levels in portuguese patients with type 2 diabetes mellitus

Journal of Investigative Medicine

Volumn 62, Issue 2, 2014, Pages 350-353

  Neuparth, Maria João ^a,b   Proença, Jorge Brandão ^b   Santos Silva, Alice ^a,c   Coimbra, Susana ^b,c  

^a UNIVERSITY OF PORTO   (Portugal)

^b INSTITUTO DE INVESTIGAÇÃO E FORMAÇÃO AVANÇADA EM CIÊNCIAS E TECNOLOGIAS DA SAÚDE   (Portugal)

^c UNIVERSITY OF PORTO   (Portugal)

Author keywords

Adipokines; Body mass index; Inflammation; Lipid peroxidation; Physical exercise

Indexed keywords

ADIPONECTIN; C REACTIVE PROTEIN; CHEMERIN; GLUCOSE; GLYCOSYLATED HEMOGLOBIN; LEPTIN; OXIDIZED LOW DENSITY LIPOPROTEIN;

ADULT; ARTICLE; BODY MASS; CONTROLLED STUDY; EXERCISE; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; INFLAMMATION; LIPID METABOLISM; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; OXIDATIVE STRESS; PROTEIN BLOOD LEVEL; WALKING;

AGED; BIOLOGICAL MARKERS; CHEMOKINES; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; EXERCISE; FEMALE; HUMANS; MALE; MIDDLE AGED; PORTUGAL; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; WALKING;

EID: 84896764707     PISSN: 10815589     EISSN: 17088267     Source Type: Journal    
DOI: 10.2310/JIM.0000000000000025     Document Type: Article

References (20)

1. Sell H, Eckel J. Chemotactic cytokines, obesity and type 2 diabetes: in vivo and in vitro evidence for a possible causal correlation? Proc Nutr Soc. 2009; 68: 378-384.
2. Oh DK, Ciaraldi T, Henry RR. Adiponectin in health and disease. Diabetes Obes Metab. 2007; 9: 282-289.
3. Enriori PJ, Evans AE, Sinnayah P, et al. Leptin resistance and obesity. Obesity (Silver Spring). 2006; 14(SUPPL. 5): 254S-258S.
4. Rondinone CM. Adipocyte-derived hormones, cytokines, and mediators. Endocrine. 2006; 29: 81-90.
5. Hopps E, Canino B, Caimi G. Effects of exercise on inflammation markers in type 2 diabetic subjects. Acta Diabetol. 2011; 48: 183-189.
6. Bozaoglu K, Bolton K, McMillan J., et al. Chemerin is a novel adipokine associated with obesity and metabolic syndrome. Endocrinology. 2007; 148: 4687-4694.
7. Goralski KB, McCarthy TC, Hanniman E.A., et al. Chemerin, a novel adipokine that regulates adipogenesis and adipocyte metabolism. J Biol Chem. 2007; 282: 28175-28188.
8. Chakaroun R, Raschpichler M, Kloting N., et al. Effects of weight loss and exercise on chemerin serum concentrations and adipose tissue expression in human obesity. Metabolism. 2012; 61: 706-714.
9. Ernst MC, Issa M, Goralski K.B., et al. Chemerin exacerbates glucose intolerance in mouse models of obesity and diabetes. Endocrinology. 2010; 151: 1998-2007.
10. Stefanov T, Blüher M, Vekova A., et al. Circulating chemerin decreases in response to a combined strength and endurance training. Endocrine. 2013 Jun 20. [Epub ahead of print].
11. Saremi A, Shavandi N, Parastesh M., et al. Twelve-week aerobic training decreases chemerin level and improves cardiometabolic risk factors in overweight and obese men. Asian J Sports Med. 2010; 1: 151-158.
12. Venojärvi M., Wasenius N, Manderoos S., et al. Nordic walking decreased circulating chemerin and leptin concentrations in middle-aged men with impaired glucose regulation. Ann Med. 2013; 45: 162-170.
13. Sell H, Laurencikiene J, Taube A., et al. Chemerin is a novel adipocyte-derived factor inducing insulin resistance in primary human skeletal muscle cells. Diabetes. 2009; 58: 2731-2740.
14. Lehrke M, Becker A, Greif M., et al. Chemerin is associated with markers of inflammation and components of the metabolic syndrome but does not predict coronary atherosclerosis. Eur J Endocrinol. 2009; 161: 339-344.
15. Kim SH, Lee SH, Ahn K.Y., et al. Effect of lifestyle modification on serum chemerin concentration and its association with insulin sensitivity in overweight and obese adults with type 2 diabetes. Clin Endocrinol (Oxf). 2013 May 18. [Epub ahead of print].
16. Ricci R, Bevilacqua F. The potential role of leptin and adiponectin in obesity: a comparative review. V e t J. 2012; 191: 292-298.
17. Hotta K, Funahashi T, Arita Y., et al. Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients. Arterioscler Thromb Vasc Biol. 2000; 20: 1595-1599.
18. Bahceci M, Gokalp D, Bahceci S., et al. The correlation between adiposity and adiponectin, tumor necrosis factor alpha, interleukin-6 and high sensitivity C-reactive protein levels. Is adipocyte size associated with inflammation in adults? J Endocrinol Invest. 2007; 30: 210-214.
19. Tilg H, Moschen AR. Role of adiponectin and PBEF/visfatin as regulators of inflammation: involvement in obesity-associated diseases. Clin Sci (Lond). 2008; 114: 275-288.
20. Kostic N, Caparavic Z, Ilic S., et al. Exercise-induced oxidative stress and antioxidant enzyme activity in type 2 diabetic patients with and without diastolic dysfunction and hypertension. Srp Arh Celok Lek. 2009; 137: 146-151.